Skip to main content

Table 1 Overview of criteria for referral recommendations

From: Referral criteria for chronic kidney disease: implications for disease management and healthcare expenditure—analysis of a population-based sample

Guideline definition

Study data definition

Referral criteria

DEGAM

DGfN/DGIM

NICE 2014

KDIGO

Kidney function

  GFR

eGFR (ml/min)

 < 30 or 30–59 b and one of the following criteria

 < 45 or 45–59 and one of the following criteria

 < 30 or 30–59 and one of the following criteria

 < 30 or 30–59 and one of the following criteria

  GFR progression > 5 ml/min / year

mean eGFR reduction > 5 ml/min from first to second follow-up examination

 

x

  

  GFR progression > 5 ml/min / year or GFR reduction ≥ 25% / year

mean eGFR reduction > 5 ml/min from first to second follow-up examination or mean eGFR reduction of ≥ 25%

   

x

  GFR progression ≥ 15 ml/ min / year or GFR reduction ≥ 25% / year

mean eGFR reduction > 15 ml/min from first to second follow-up examination or mean eGFR reduction of ≥ 25%

  

x

 

Hypertension refractory to treatment

  BP > 150 and/or > 90 mmHg and ≥ 3 antihypertensives

BP: mean systolic BP of 2. and 3. measurement

Antihypertensives: ATC-codes C02-C09

x

x

  

  BP > 150 and/or > 90 mmHg and ≥ 4 antihypertensives

BP: mean systolic BP of 2. and 3. measurement

Antihypertensives: ATC-codes C02-C09

  

x

x

Proteinuria

  Proteinuria > 200 mg/l, subjects with diabetes: > 20 mg/l

Urine albumin dipstick category, subjects with diabetes: urine protein dipstick category

 

x

  

  Albuminuria ≥ 300 mg/g or ≥ 30 mg/mmol

ACR

   

x

  Proteinuria ≥ 70 mg/mmol and non-diabetic

ACR

  

x

 

  Albuminuria ≥ 30 mg/g or ≥ 3 mg/mmol

ACR

x

   

  ACR ≥ 30 mg/mmol and haematuria

ACR and urine dipstick category red blood cells +  + 

  

x

 

Haematuria

  Micro- or macrohematuria

urine dipstick category red blood cells +  + a

 

x

 

x

  Haematuria without known urologic cause

urine dipstick category red blood cells +  + a

x

   

Morphologic and structural kidney abnormalities

  Morphologic kidney changes

ICD-10-GM codes

• at least one billing code one year prior to study examination of second follow-up (N02.-, N20.-)

• at least one billing code five years prior to study examination of second follow-up (N11.-, N13.-, N26.-, N28.-, C64.-, D41.0, Q61.-, Q63.-, I70.1)

 

x

  

  Kidney stones

ICD-10-GM codes N20.-, at least one billing code one year prior to study examination of second follow-up

   

x

  Renal artery stenosis

ICD-10-GM code I70.1, at least one billing code five years prior to study examination of second follow-up

  

x

 

Miscellaneous

  Hypocalcaemia

 < 2.12 mmol/l

 

x

  

  Hyperphosphatemia

 > 1.6 mmol/l

 

x

  

  Abnormalities of serum potassium

Serum potassium < 3.7 mmol/l or > 5.1 mmol/l

   

x

Inherited kidney disease

ICD-10-GM codes, at least one billing code five years prior to study examination of second follow-up (Q61.-, Q63.-)

  

x

x

Anaemia

WHO reference values haemoglobin, female: < 7.4 mmol/l, male: < 8.1 mmol/l

 

x

  
  1. ACR Albumin-Creatinin-Ratio, ATC Anatomical Therapeutic Chemical (ATC) Classification System Code, BP Blood Pressure, eGFR estimated Glomerular Filtration Rate, ICD-10-GM DEGAM: German society of general practice and family medicine, DGIM German society of internal medicine, DGfN German society of Nephrology, German modification of the 10th revision of the International Classification of Diseases, NICE National Institute of Health and Care Excellence, KDIGO Kidney Disease Improving Global Outcomes, WHO World Health Organisation
  2. a KDIGO criterium “erythrocyte cylinder or erythrocytes in spot urine > 20/high power field” was defined by substituting 1 µl for one high power field, which correlates to a 2 +  + urinary dip stick score in SHIP data
  3. b DEGAM made a good clinical practice point that younger patients with a low eGFR should be referred liberally, while in older patients (> 70 years old) with eGFR < 30 ml/min comorbidity, life expectancy and individual patient goals should be considered